ZS Pharma is requesting FDA approval for sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia.
Patients remain largely uninformed about the dangers of unnecessary disease screening and overdiagnosis.
The FDA today approved eluxadoline and rifaximin to treat irritable bowel syndrome with diarrhea.
West Virginia’s highest appellate court recently ruled prescription drug abusers can sue pharmacists for enabling their addictions.
Amgen has terminated its co-development and commercialization of brodalumab with AstraZeneca after observing suicidal ideation and behavior in clinical trial participants.